期刊档案 · 医学-传染病学
Infection
ISSN 0300-8126 · eISSN 1439-0973 · Springer Berlin Heidelberg · GERMANY · Bimonthly · 创刊 1973
Infection 中科院 医学 3区(2025 年升级版),影响因子 3.91,混合开放获取,APC 约 4,790 美元,近 24 个月 114 篇文章投稿到接收中位 69 天,录用比例较易(社区反馈),2025 年发文 261 篇,SCIE、Scopus 收录。
研究范围
研究范围与定位
Infection 由 Springer Berlin Heidelberg 出版,属中科院医学大类(2025 升级版3区)。按 OpenAlex 近年发文统计,该刊主要发表 Antibiotics Pharmacokinetics and Efficacy、Antibiotic Resistance in Bacteria、Pneumonia and Respiratory Infections 等主题的论文,这 3 个主题约占 27.3%。(根据 OpenAlex 主题统计与中科院分区数据生成)
The primary aim of Infection is to be a forum for the presentation and discussion of clinically relevant information on infectious diseases for readers and contributors from all over the world. Articles deal with the etiology, pathogenesis, diagnosis and treatment of infectious diseases in the outpatient as well as in the inpatient setting. Public health issues of local, regional or international importance related to infectious diseases are featured, as well as progress and problems in hospital epidemiology. The main contents of the journal include original articles describing results of research projects, brief reports on new observations that enhance the knowledge of clinicians, and state-of-the-art reviews on topics that are relevant to physicians diagnosing or treating infectious diseases. Case reports describing new infectious etiologies or clinical manifestations are also welcome. Finally, the correspondence section is open to readers who want to respond to articles published in Infection or to succinctly present information to the general readership. Because infectious diseases often present with characteristic clinical pictures that can be seen upon inspection and because imaging and microscopy are an essential part of infection diagnosis, the “Images” section of Infection was created to focus on high-quality pictures with short texts in abstract form.The content of Infection covers several fields, as represented in the various sections of the board of editors, which range from clinical infectious diseases in general to pediatric infectious diseases, clinical microbiology and diagnostics, healthcare-associated infections, antimicrobial use, healthcare quality, fungal infections, and viral infections, including the broad fields of HIV and viral hepatitis. Parasitic infections, international health and travel medicine are among the journal’s newest focus areas.Infection adheres to a high standard of quality for all published material. Each article undergoes a peer-review process. At the same time the editors aim to keep the interval between submission and publication as short as possible. For articles describing particularly timely or important new findings, accelerated peer-review and fast-track publication options are made available.
摘自期刊官网 Aims & Scope
研究方向(LetPub):医学-传染病学
主编 Johannes Bogner出版商官网
编委会国家分布:未见中国大陆编委;主要国家 德国 22、意大利 11、美国 9、瑞士 3、奥地利 2(共 58 位编委标注了国家) 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Antibiotics Pharmacokinetics and EfficacyMedicine11.4%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology9.7%
- Pneumonia and Respiratory InfectionsMedicine6.3%
- Antimicrobial Resistance in StaphylococcusMedicine5.6%
- Urinary Tract Infections ManagementMedicine5.3%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology5%
- Streptococcal Infections and TreatmentsMedicine4.1%
- Antibiotic Use and ResistanceImmunology and Microbiology3.8%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 传染病学INFECTIOUS DISEASES | 3 区 |
Top 期刊:否综述期刊:否
《新锐期刊分区表》( 2026年3月发布)医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 传染病学INFECTIOUS DISEASES | 2 区 |
Top 期刊:否综述期刊:未标注
期刊分区表( 2023年12月旧的升级版)医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 传染病学INFECTIOUS DISEASES | 3 区 |
Top 期刊:否综述期刊:否
数据库收录
SCIEScopusLetPub
国际期刊预警名单:各版本均未列入LetPub
期刊官网自述收录
MEDLINEEmbaseCASCAB AbstractsCurrent Contents出版商官网
其他:Google Scholar、EBSCO、ProQuest、Dimensions、CNKI、Baidu、AGRICOLA、Naver、OCLC、Portico、CLOCKSS、Semantic Scholar
期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 3.91LetPub ·
- 影响因子(出版商公布) 2025
- 3.9出版商官网 ·
- 五年影响因子(出版商公布) 2025
- 3.7出版商官网 ·
- CiteScore 2026-06
- 7.4LetPub ·
- SJR 2026-06
- 1.09LetPub ·
- SNIP 2026-06
- 1.23LetPub ·
- h-index
- 66LetPub ·
- h-index
- 119OpenAlex ·
- i10-index
- 3,662OpenAlex ·
- 两年平均被引
- 4.1OpenAlex ·
- 自引率
- 2.6%LetPub ·
- Gold OA 文章占比
- 73.19%LetPub ·
发文规模
- 年文章数
- 219LetPub ·
- 年发文量(出版商公布)
- 2,025出版商官网 ·
- 年下载量(出版商公布) 2025
- 1,500,000出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 8,064 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 245 | 136 | 79 |
| 2025 | 261 | 182 | 853 |
| 2024 | 296 | 218 | 2,356 |
| 2023 | 186 | 152 | 2,172 |
| 2022 | 230 | 182 | 3,485 |
| 2021 | 189 | 147 | 5,276 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
69 天投稿到接收中位数 · P25–P75 43 天 – 105 天
- 接收到上线
- 中位数 14 天(114 篇)
- 投稿到上线
- 中位数 85 天
- 样本
- 114 篇有投稿与接收日期的文章(窗口内共 567 篇),最近一篇接收于
只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度(社区反馈)
- 较慢,6-12周LetPub ·
- 平均录用比例(社区反馈)
- 较易LetPub ·
- 投稿到首次决定
- 2 天出版商官网 ·
- 评审方式
- 双盲同行评审出版商官网
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
订阅期刊,作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 4,790 / EUR 3,790 / GBP 2,990 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取;按订阅方式发表通常不收费。
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点4 项,摘自作者指南
- 摘要
- 150–250 词
- 关键词
- ≥ 4 个
- 参考文献格式
- 顺序编码制(按引用顺序编号)
- 推荐审稿人
- 可选
接收的文章类型14 种,含篇幅限制
- addendumAddendum: Original papers, lectures, or summaries of lectures or conference papers, and open studies supported by a society, health authority or companies are p…未说明篇幅
- brief reportResearch (Clinical and Epidemiological Study): Original papers are full-length reports of original research. They should contain no more than 35,000 characters …未说明篇幅
- case reportResearch (Clinical and Epidemiological Study): Original papers are full-length reports of original research. They should contain no more than 35,000 characters …未说明篇幅
- correspondenceLetters to the Editor are encouraged. Letters may report new or important observations or provide comments or criticisms pertaining to developments in infectiou…参考文献 ≤ 5
- correspondence (letter to the editor)Correspondence (Letter to the Editor): Letters to the Editor are encouraged. Letters may report new or important observations or provide comments or criticisms …未说明篇幅
- editorialResearch (Clinical and Epidemiological Study): Original papers are full-length reports of original research. They should contain no more than 35,000 characters …未说明篇幅
- imageImage: The Image article format is intended to provide classic images of common and of infrequently encountered infectious diseases.未说明篇幅
- mini reviewResearch (Clinical and Epidemiological Study): Original papers are full-length reports of original research. They should contain no more than 35,000 characters …未说明篇幅
- original paperResearch (Clinical and Epidemiological Study): Original papers are full-length reports of original research. They should contain no more than 35,000 characters …未说明篇幅
- original researchResearch (Clinical and Epidemiological Study): Original papers are full-length reports of original research. They should contain no more than 35,000 characters …未说明篇幅
- research (clinical and epidemiological study)Research (Clinical and Epidemiological Study): Original papers are full-length reports of original research. They should contain no more than 35,000 characters …未说明篇幅
- reviewResearch (Clinical and Epidemiological Study): Original papers are full-length reports of original research. They should contain no more than 35,000 characters …未说明篇幅
- review articleResearch (Clinical and Epidemiological Study): Original papers are full-length reports of original research. They should contain no more than 35,000 characters …未说明篇幅
- supplementSupplement: See Addendum above. Published separately and distributed to all subscribers.未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、查重、试验注册 / 报告规范
- AI 使用 Generative AI Images
请核查Springer关于生成式AI图像的政策,并确保您的工作符合其中所述的原则。 模型中文摘要
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
原文 ↗出版商官网 ·- 作者资格 Authorship principles
作者身份原则要求所有作者同意内容并明确同意投稿,且已获得工作所在机构负责部门的同意;出版社不规定何种贡献可构成作者身份,建议作者遵循适用的作者身份指南。 模型中文摘要
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
原文 ↗出版商官网 ·- 利益冲突 Competing Interests
作者应披露与所投稿件直接或间接相关的利益,包括开始工作前3年内的利益,3年之外若可能被合理认为影响所投稿件的利益也须披露。 模型中文摘要
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclo…
原文 ↗出版商官网 ·- 数据可用性 Data availability statements
所有原创研究必须包含数据可用性声明,说明如何获取支持结果与分析的数据;若无法公开共享数据,应说明访问方式及再利用条件,并应在数据收集前取得并记录参与者同意。 模型中文摘要
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
原文 ↗出版商官网 ·- 出版伦理 Ethical standards
稿件必须声明所有人类和动物研究已获相应伦理委员会批准,并符合1964年《赫尔辛基宣言》及其后续修订的伦理标准,且所有受试者在纳入研究前均给予知情同意。 模型中文摘要
Manuscripts submitted for publication must contain a statement to the effect that all human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed conse…
原文 ↗出版商官网 ·- 许可与版权 Copyright
Open Choice文章无需转让版权,版权仍归作者所有;选择开放获取即表示作者同意在知识共享许可下发表文章。 模型中文摘要
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
原文 ↗出版商官网 ·- 开放获取 Open access publishing
有关在Infection期刊开放获取发表的更多信息(包括费用、资助和许可),请访问期刊的开放获取出版页面。 模型中文摘要
To find out more about publishing your work Open Access in Infection, including information on fees, funding and licences, visit our Open access publishing page. Back to top
原文 ↗出版商官网 ·- 查重
重要提示:期刊可能使用软件对稿件进行抄袭筛查。 模型中文摘要
Important note: the journal may use software to screen for plagiarism.
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical Trial Registration
根据WHO定义,临床试验是前瞻性地将人类参与者分配到一项或多项健康相关干预以评估健康结局效果的研究;前瞻性注册试验需提供注册号和注册日期,回顾性注册试验需注明“retrospectively registered”。 模型中文摘要
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Springer Berlin Heidelberg
- 出版国家或地区
- GERMANY
- 出版语言
- English
- 出版周期
- Bimonthly
- 创刊年份
- 1973
- ISSN
- 0300-8126
- 电子版 ISSN
- 1439-0973
- 官网最新一期
- Volume 54, Issue 4(2026 年 8 月)
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗LetPub
- 作者指南 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Infection 的常见问题
Infection 是中科院几区期刊?
2025 年升级版分区表中,Infection 为医学 3区,小类 传染病学 3 区。2026 年新锐版分区表中为医学 2区。不同版本与大小类分区不能混用。
Infection 的影响因子是多少?
LetPub 汇总的最新公布影响因子为 3.91,CiteScore 为 7.4,h-index 为 119。
Infection 的审稿周期多长?
按 2024年10月至2026年10月(近 24 个月)114 篇已发表文章登记的日期,投稿到接收的中位数为 69 天(四分位 43–105 天);投稿社区反馈的平均审稿速度为6–12 周,平均录用比例反馈为“较易”。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。
Infection 的投稿格式要求是什么?
据期刊作者指南:摘要:150–250 词;关键词:≥ 4 个;参考文献格式:顺序编码制(按引用顺序编号);推荐审稿人:可选。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
Infection 的编委会里有中国学者吗?
期刊官网编委会页面上标注了国家的 58 位编委中,没有中国大陆学者;人数最多的国家是 德国(22 位)、意大利(11 位)、美国(9 位)。统计按编委会页面列出的机构国家计,仅供参考。
Infection 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,Infection 被 SCIE、Scopus 收录。期刊官网自述还被 MEDLINE、Embase、CAS、CAB Abstracts、Current Contents 收录,该清单未与各数据库逐一核对。
Infection 是开放获取期刊吗?版面费多少?
Infection 为混合开放获取。选择开放获取发表时APC 约 4,790 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。